Shared by
beno
Fundamentals
N/a
Catalysts / News / Painting the picture
-Corona virus sympathy
-Health officials say virus vaccine development has 'no glitches'
-Feb 11 2020: $500m IPO @ $19 per share
-mRNA-1273 coronavirus vaccine sent for testing
-March 16 2020: First human trial of COVID-19 vaccine
-April 15 2020: PT increase to 41, Making new ATH's
-April 16 2020: Wins $483 Million US Government Award To Develop Coronavirus Vaccine
Technical Analysis
-Intraday pattern: Consolidation
-Levels: 43.5, 45, 47, 48, 50
Original Plan / Strategy
First test short of 46.5 level with half dollar confluence
Review
Went further than anticipated so I scratched the lot on the way back down, trade ended up working so initial thesis was right, trade just took more time to play out.
Execution detail:
| Date/time | Symbol | Side | Price | Position |
|---|---|---|---|---|
| 2020-04-17 13:51:15 | MRNA | sell | $46.450 | short |
| 2020-04-17 13:55:34 | MRNA | buy | $46.450 | 0 |
Leave a comment about this trade!
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!